4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001181431-13-043337
Director sold 12,500 shares at $12.41 ($155,125)
- Director acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WHITFIELD ROY A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-08-05 | Exercise or conversion : show line 1 in the form | +12,500 | $11.41 | $142,625 | 32,500 | D |
| 2013-08-05 | Sale : show line 2 in the form | −12,500 | $12.41 | $155,125 | 20,000 | D |
| Open-market sales · 12,500 sh · avg $12.41 · $155,125 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-08-05 | Exercise or conversion : show line 3 in the form Stock Option | −12,500 | $11.41 | 2013-09-03 | 12,500 | 0 | D |
Loading xslF345X03/rrd387477.xml…